• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可变剪接事件作为肺鳞状细胞癌的诱人特征

Switched alternative splicing events as attractive features in lung squamous cell carcinoma.

作者信息

He Boxue, Wei Cong, Cai Qidong, Zhang Pengfei, Shi Shuai, Peng Xiong, Zhao Zhenyu, Yin Wei, Tu Guangxu, Peng Weilin, Tao Yongguang, Wang Xiang

机构信息

Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, 410011, China.

Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, Second Xiangya Hospital, Central South University, Changsha, 410011, China.

出版信息

Cancer Cell Int. 2022 Jan 5;22(1):5. doi: 10.1186/s12935-021-02429-2.

DOI:10.1186/s12935-021-02429-2
PMID:34986865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8734344/
Abstract

BACKGROUND

Alternative splicing (AS) plays important roles in transcriptome and proteome diversity. Its dysregulation has a close affiliation with oncogenic processes. This study aimed to evaluate AS-based biomarkers by machine learning algorithms for lung squamous cell carcinoma (LUSC) patients.

METHOD

The Cancer Genome Atlas (TCGA) database and TCGA SpliceSeq database were utilized. After data composition balancing, Boruta feature selection and Spearman correlation analysis were used for differentially expressed AS events. Random forests and a nested fivefold cross-validation were applied for lymph node metastasis (LNM) classifier building. Random survival forest combined with Cox regression model was performed for a prognostic model, based on which a nomogram was developed. Functional enrichment analysis and Spearman correlation analysis were also conducted to explore underlying mechanisms. The expression of some switch-involved AS events along with parent genes was verified by qRT-PCR with 20 pairs of normal and LUSC tissues.

RESULTS

We found 16 pairs of splicing events from same parent genes which were strongly related to the splicing switch (intrapair correlation coefficient = - 1). Next, we built a reliable LNM classifier based on 13 AS events as well as a nice prognostic model, in which switched AS events behaved prominently. The qRT-PCR presented consistent results with previous bioinformatics analysis, and some AS events like ITIH5-10715-AT and QKI-78404-AT showed remarkable detection efficiency for LUSC.

CONCLUSION

AS events, especially switched ones from the same parent genes, could provide new insights into the molecular diagnosis and therapeutic drug design of LUSC.

摘要

背景

可变剪接(AS)在转录组和蛋白质组多样性中发挥着重要作用。其失调与致癌过程密切相关。本研究旨在通过机器学习算法评估肺鳞状细胞癌(LUSC)患者基于AS的生物标志物。

方法

利用癌症基因组图谱(TCGA)数据库和TCGA SpliceSeq数据库。在数据组成平衡后,使用Boruta特征选择和Spearman相关性分析来检测差异表达的AS事件。应用随机森林和嵌套五重交叉验证构建淋巴结转移(LNM)分类器。基于随机生存森林结合Cox回归模型构建预后模型,并据此绘制列线图。还进行了功能富集分析和Spearman相关性分析以探索潜在机制。通过qRT-PCR对20对正常组织和LUSC组织中一些与剪接转换相关的AS事件及其亲本基因的表达进行了验证。

结果

我们发现来自同一亲本基因的16对剪接事件与剪接转换密切相关(配对内相关系数=-1)。接下来,我们基于13个AS事件构建了一个可靠的LNM分类器以及一个良好的预后模型,其中转换的AS事件表现突出。qRT-PCR结果与先前的生物信息学分析一致,一些AS事件如ITIH5-10715-AT和QKI-78404-AT对LUSC具有显著的检测效率。

结论

AS事件,特别是来自同一亲本基因的转换事件,可为LUSC的分子诊断和治疗药物设计提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/0e09bfc35cc6/12935_2021_2429_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/82079e9707ca/12935_2021_2429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/eab33d5de248/12935_2021_2429_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/88cc40068e1b/12935_2021_2429_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/fd2dce35b821/12935_2021_2429_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/63085ac9ed86/12935_2021_2429_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/9c48e91ac788/12935_2021_2429_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/6b5170ecbc94/12935_2021_2429_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/96e8b3993e90/12935_2021_2429_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/0e09bfc35cc6/12935_2021_2429_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/82079e9707ca/12935_2021_2429_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/eab33d5de248/12935_2021_2429_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/88cc40068e1b/12935_2021_2429_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/fd2dce35b821/12935_2021_2429_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/63085ac9ed86/12935_2021_2429_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/9c48e91ac788/12935_2021_2429_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/6b5170ecbc94/12935_2021_2429_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/96e8b3993e90/12935_2021_2429_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9689/8734344/0e09bfc35cc6/12935_2021_2429_Fig9_HTML.jpg

相似文献

1
Switched alternative splicing events as attractive features in lung squamous cell carcinoma.可变剪接事件作为肺鳞状细胞癌的诱人特征
Cancer Cell Int. 2022 Jan 5;22(1):5. doi: 10.1186/s12935-021-02429-2.
2
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.使用机器学习方法探索肺腺癌中预测性和预后性可变剪接特征
J Transl Med. 2020 Dec 7;18(1):463. doi: 10.1186/s12967-020-02635-y.
3
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中生存相关可变剪接特征的鉴定
Front Oncol. 2020 Sep 30;10:587343. doi: 10.3389/fonc.2020.587343. eCollection 2020.
4
Novel, alternative splicing signature to detect lymph node metastasis in prostate adenocarcinoma with machine learning.利用机器学习检测前列腺腺癌淋巴结转移的新型可变剪接特征
Front Oncol. 2023 Jan 13;12:1084403. doi: 10.3389/fonc.2022.1084403. eCollection 2022.
5
Prognostic alternative mRNA splicing signature in non-small cell lung cancer.非小细胞肺癌中的预后性可变mRNA剪接特征
Cancer Lett. 2017 May 1;393:40-51. doi: 10.1016/j.canlet.2017.02.016. Epub 2017 Feb 20.
6
Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.基于生物信息学分析评估肺鳞癌患者 HOXA11 水平及潜在分子通路的研究
World J Surg Oncol. 2018 Jun 18;16(1):109. doi: 10.1186/s12957-018-1375-9.
7
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
8
Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma.基于肺鳞状细胞癌免疫相关基因的预后模型鉴定
Front Oncol. 2020 Sep 2;10:1588. doi: 10.3389/fonc.2020.01588. eCollection 2020.
9
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.全面分析和建立剪接事件的预测模型,揭示三阴性乳腺癌的预后预测因子和免疫微环境特征。
J Transl Med. 2020 Jul 28;18(1):286. doi: 10.1186/s12967-020-02454-1.
10
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.

引用本文的文献

1
Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma.肺鳞状细胞癌中的全基因组DNA甲基化及基于DNA甲基化的生物标志物
iScience. 2023 Jun 5;26(7):107013. doi: 10.1016/j.isci.2023.107013. eCollection 2023 Jul 21.

本文引用的文献

1
Global Alternative Splicing Defects in Human Breast Cancer Cells.人类乳腺癌细胞中的全局可变剪接缺陷
Cancers (Basel). 2021 Jun 20;13(12):3071. doi: 10.3390/cancers13123071.
2
ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.ITIH5 是一个 p53 反应基因,通过下调 KLF4 的转录活性抑制黑色素瘤细胞的生长和转移。
Cell Death Dis. 2021 May 2;12(5):438. doi: 10.1038/s41419-021-03707-7.
3
Development of alternative splicing signature in lung squamous cell carcinoma.
肺鳞癌中可变剪接特征的开发。
Med Oncol. 2021 Mar 27;38(5):49. doi: 10.1007/s12032-021-01490-1.
4
SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer.SRSF1 通过调节 Bcl-x 的剪接并与肺癌中的 PIK3C3 相互作用来抑制自噬。
Signal Transduct Target Ther. 2021 Mar 5;6(1):108. doi: 10.1038/s41392-021-00495-6.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through Merlin.TNIK 是肺鳞状细胞癌的治疗靶点,通过 Merlin 调节 FAK 的激活。
Cancer Discov. 2021 Jun;11(6):1411-1423. doi: 10.1158/2159-8290.CD-20-0797. Epub 2021 Jan 25.
7
RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials.RAINFOREST:一种随机森林方法,用于预测(失败)临床药物试验数据中的治疗获益。
Bioinformatics. 2020 Dec 30;36(Suppl_2):i601-i609. doi: 10.1093/bioinformatics/btaa799.
8
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.使用机器学习方法探索肺腺癌中预测性和预后性可变剪接特征
J Transl Med. 2020 Dec 7;18(1):463. doi: 10.1186/s12967-020-02635-y.
9
Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics.选择性剪接:拓宽癌症生物标志物和治疗学的领域。
Int J Mol Sci. 2020 Nov 27;21(23):9032. doi: 10.3390/ijms21239032.
10
Survival prediction models since liver transplantation - comparisons between Cox models and machine learning techniques.肝移植后生存预测模型——Cox 模型与机器学习技术的比较。
BMC Med Res Methodol. 2020 Nov 16;20(1):277. doi: 10.1186/s12874-020-01153-1.